Status: current, Not sufficiently defined by necessary conditions definition status. Date: 24-Jan 2018. Module: SNOMED CT United Kingdom drug extension module
Descriptions:
| Id | Description | Lang | Type | Status | Case? | Module |
| 106071601000001119 | Dinutuximab beta (substance) | en | Fully specified name | Active | Entire term case sensitive | SNOMED CT United Kingdom drug extension module |
| 106192401000001110 | Dinutuximab beta | en | Synonym | Active | Only initial character case insensitive | SNOMED CT United Kingdom drug extension module |
| Outbound Relationships | Type | Target | Active | Characteristic | Refinability | Group | Values |
| Dinutuximab beta | Is a | Immunoglobulin IgG1 | true | Inferred relationship | Existential restriction modifier |
| Inbound Relationships | Type | Active | Source | Characteristic | Refinability | Group |
| Dinutuximab beta 20mg/4.5ml solution for infusion vials | Has specific active ingredient | True | Dinutuximab beta | Inferred relationship | Existential restriction modifier | |
| Qarziba 20mg/4.5ml concentrate for solution for infusion vials (EUSA Pharma (UK) Ltd) | Has specific active ingredient | True | Dinutuximab beta | Inferred relationship | Existential restriction modifier | |
| Dinutuximab beta 20mg/4.5ml solution for infusion vials 1 vial | Has specific active ingredient | True | Dinutuximab beta | Inferred relationship | Existential restriction modifier | |
| Qarziba 20mg/4.5ml concentrate for solution for infusion vials (EUSA Pharma (UK) Ltd) 1 vial | Has specific active ingredient | True | Dinutuximab beta | Inferred relationship | Existential restriction modifier |
This concept is not in any reference sets
FHIR